BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2483984)

  • 21. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.
    Lasson A; Ohlsson K
    Scand J Gastroenterol; 1984 Sep; 19(6):779-86. PubMed ID: 6083596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticoagulants and changes in the coagulation status of patients with chronic obstructive lung disease and various degrees of respiratory failure].
    Mariĭnov Kh; Petrova D; Kamenov V; Tikhova D
    Vutr Boles; 1988; 27(1):86-93. PubMed ID: 3414091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
    Rothschild BM; Thompson LD; Pifer DD; Chesney CM
    Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma proteinase inhibitors.
    Bodmer JL; Schnebli HP
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibronectin and other immunologic parameters in chronic polyarthritis].
    Siegmeth W; Minar E; Graninger W; Pirich K; Zazgornik J
    Z Rheumatol; 1984; 43(1):27-9. PubMed ID: 6201023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].
    Hainaut J; Dhennin C; Guilbaud J
    Nouv Rev Fr Hematol (1978); 1982; 24(6):375-81. PubMed ID: 6188103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P; Lasson A; Hage E
    J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
    Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
    Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of neutral leukocyte proteases by horse protease inhibitors].
    von Fellenberg R; Pellegrini A
    Schweiz Arch Tierheilkd; 1979 Aug; 121(8):405-12. PubMed ID: 93783
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of plasma endothelin-1 in aged patients with chronic obstructive pulmonary disease in its clinical significance].
    Feng CS; Huang NQ; Zeng Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Oct; 16(5):287-9, 320. PubMed ID: 7923434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Main proteolytic inhibitors in ocular herpes].
    Chesnokova NB; Kasavina BS; Maĭchuk IuF; Kazachenko MA; Shchipanova AI
    Vopr Med Khim; 1981; 27(5):663-5. PubMed ID: 6171934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
    Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
    Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The protease inhibitor potential in newborns with respiratory distress syndrome].
    Weissbach G; Domula M; Lenk H; Rogos R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):89-102. PubMed ID: 88394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of natural protease inhibitors on hemostasis and serum proteolysis blockers in patients with pulmonary tuberculosis].
    Morozova TI; Khudzik LB
    Probl Tuberk; 1993; (3):27-30. PubMed ID: 7527148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the clinical significance of determining the level of plasma fibronectin in acute poisoning].
    Shimanko II; Nazarenko AA; Osmanov SK; Tsepliaeva GI; Kuz'mina NS; Lebedeva IuN; Zimina LN
    Vestn Akad Med Nauk SSSR; 1990; (3):37-9. PubMed ID: 2353535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Plasma fibronectin in chronic liver diseases].
    Soresi M; Di Martino D; Montalto G; Carroccio A; Ruggeri MI; Bascone F; Ippolito S; Notarbartolo A
    Recenti Prog Med; 1993 Sep; 84(9):602-7. PubMed ID: 8210624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
    Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
    Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombotic complications originating in the lung in chronic respiratory insufficiency].
    Angelov A; Zekov C
    Z Erkr Atmungsorgane; 1984; 162(3):256-61. PubMed ID: 6485387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma antithrombin III and alpha 2-microglobulin in chronic respiratory insufficiency].
    Quartarone M; Coppolino E; Maiorana MC; Ciraolo O
    G Clin Med; 1986 Apr; 67(2):103-4. PubMed ID: 2431947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.